The Behcet’s Disease: An Uncommon Cause of Venous Thrombosis in the Tropical Area: 10 Cases
- 1 Department of Internal Medicine, Dalal Jamm Hospital, Dakar, Senegal
- 2 Department of Internal Medicine, Le Dantec Hospital, Dakar, Senegal
- 3 Department of Cardiology, Le Dantec Hospital, Dakar, Senegal
- 4 Department of Internal Medicine, Le Dantec Hospital, Dakar, Senegal
- 5 Department of Internal Medicine, Dalal Jamm Hospital, Dakar, Senegal
- 6 Department of Internal Medicine, Pikine Hospital, Pikine, Senegal
- 7 Department of Internal Medicine, Le Dantec Hospital, Dakar, Senegal
Abstract
Introduction: The Behcet’s disease is deemed to be scarce in Black Africa where data are still scattered. The purpose of our study is to describe the epidemiological, clinical, paraclinic and evolutive particularities of the patients whose presenting symptoms of the Behcet’s diseases were a venous thrombosis. Patients and Methods : It was a descriptive, multicenter, and cross-sectional study lasting 15 months. We brought together all the cases of the Behcet’s disease revealed by venous thrombosis. The diagnosis was based on clinical criteria of the international group of study of the Behcet’s disease in 2007. Results: We have grouped 10 revealing thrombosis cases of the Behcet’s diseases during our study period. The average age was 34. The average wait period between the appearances of the early symptoms and the diagnosis of the very disease was 30 months. The admission motives were the abdominal pain (2 cases), a thrombophlebitis of the lower limb (2 cases), headaches (1 case), coma (1 case), a thrombophlebitis of the upper limb (3 cases). The thrombotic symptoms were exclusively venous-located. The seats of the thrombosis were the vena cava superior in 30% of the cases, the vena cava inferior in 20% of the cases, the veins of the lower limb in 20% of the cases, the cerebral vein in 20% of the cases, and the auxiliary vein in 10% of the cases. The treatment of the deep venous thrombosis consisted in all the cases of an effective anticoagulation associated with the colchicine. Primarily, the corticotherapy with a high dose was used in all the patients. One of them in the comatose stage, manifesting both cerebral thrombophlebitis and aseptic meningitis, had died. Conclusion: Behcet’s disease is a disease of the young adult, but it must be evoked even in old age, with a view to appropriate management, in order to avoid the complications of the disease. Although it is rare in our regions, it should be sought in the etiological assessment of venous thrombosis whatever the location.
- Houman, MH. and Bel Feki, N. (2017) Physiopathology of Behçet’s Disease. La Revue de Médecine Interne, 35, 90-96. http://doi.org/10.1016/j.revmed.2013.10.012
- Simon, F. and Chouc, P.Y. et al. (1992) Behçet’s Disease. Black African Medicine of Black Africa, 39, 658-664.
- International Team for the Revision of the International Criteria for Behcet’s Disease (2006) Evaluation of the International Criteria for Behcet’s Disease (ICBD). Clinical and Experimental Rheumatology, 24 (Supplement 42), S13.
- International Study Group for Behcet’s Disease (1990) Criteria for Diagnosis of Behçet’s Disease. Lancet, 335, 1078-1080.
- Zidi, A., Mrad, K.B.M., Hantous, S., et al. (2006) Vascular Behçet with Thoracic Localization. Journal de Radiologie, 87, 285-289. https://doi.org/10.1016/S0221-0363(06)74002-1
- Ndiaye, M. and Sow, A.S. (2015) A Valiollah Behçet’s Disease in Black Skin: A Retrospective Study of 50 Cases in Dakar. Journal of Dermatological Case Reports, 9, 98-102. https://doi.org/10.3315/jdcr.2015.1213
- Tohmé, A., Aoun, N., El-Rassi, B. and Ghayad, E. (2003) Vascular Manifestations of Behçet’s Disease: 18 Cases among 140 Patients. Revue du Rhumatisme, 70, 766-772. https://doi.org/10.1016/S1169-8330(03)00160-1
- Sagdic, K., Ozer, Zg. and Saba, D. (1996) Venous Lesions in Behçet’s Disease. European Journal of Vascular and Endovascular Surgery, 11, 437-440. https://doi.org/10.1016/S1078-5884(96)80178-X
- Erkan, F., Gül, A. and Tasali, E. (2001) E Rare Diseases. Pulmonary Manifestations of Behçet’s Disease. Thorax, 56, 572-578. https://doi.org/10.1136/thorax.56.7.572
- Gurler, A., Boyvat, A. and Tursen, U. (1997) Clinical Manifestations of Behcet’s Disease: An Analysis of 2147 Patients. Yonsei Medical Journal, 38, 423-427. https://doi.org/10.3349/ymj.1997.38.6.423
- Bang, D. (1997) Treatment of Behçet’s Disease. Yonsei Medical Journal, 38, 401-410. https://doi.org/10.3349/ymj.1997.38.6.401
- Hamza, M. (2000) Behçet’s Disease In: Kahn, M.F., Peltier, A.P., Meyer, O., Piette, J.C., Eds., Systemic Diseases and Syndromes, 4th Ed., Flammarion Medicine, Paris, 883-924.
- Ozoran, K., Düzgün, N., Gürler, A., Tutkak, H. and Tokgoz, G. (1995) Plasma von Willebrand Factor, Tissue Plasminogen Activator, Plasminogen Activator Inhibitor, and Antithrombin III Levels in Behçet’s Disease. Scandinavian Journal of Rheumatology, 24, 376-382. https://doi.org/10.3109/03009749509095184